Protalix BioTherapeutics
PLX
#8821
Rank
โ‚น16.62 B
Marketcap
โ‚น206.31
Share price
-0.90%
Change (1 day)
-7.97%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): โ‚น1.74

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is โ‚น1.88. In 2024 the company made an earnings per share (EPS) of โ‚น3.75 a decrease over its 2023 EPS that were of โ‚น11.25.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น1.74-53.48%
2024โ‚น3.75-66.67%
2023โ‚น11.25-138.71%
2022-โ‚น29.07-50%
2021-โ‚น58.14181.82%
2020-โ‚น20.63-82.11%
2019-โ‚น115.34-31.67%
2018-โ‚น168.80-72.31%
2017-โ‚น609.54124.14%
2016-โ‚น271.95-147.54%
2015โ‚น572.03-290.63%
2014-โ‚น300.086.67%
2013-โ‚น281.33130.77%
2012-โ‚น121.91-69.77%
2011-โ‚น403.2319.44%
2010-โ‚น337.59-12.2%
2009-โ‚น384.4836.67%
2008-โ‚น281.33-37.5%
2007-โ‚น450.1250%
2006-โ‚น300.083.23%
2005-โ‚น290.70138.46%
2004-โ‚น121.91-74%
2003-โ‚น468.88-0%
2002-โ‚น468.88-50%
2001-โ‚น937.75233.33%
2000-โ‚น281.33-84.21%
1999-โ‚น1,782-24%
1998-โ‚น2,344-600%
1997โ‚น468.88-16.67%
1996โ‚น562.65

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น127.53 6,700.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น452.00 24,000.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
-โ‚น10.32-650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น116.28 6,100.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel